4570 studies found for:    genital diseases AND (woman OR women OR female)
Show Display Options
Rank Status Study
1 Completed
Has Results
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED)
Conditions: Papillomavirus Infections;   Genital Diseases, Female
Interventions: Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 20/40/40/20;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 40/40/40/40;   Biological: Quadrivalent HPV (Types 6,11,16,18) L1 VLP Vaccine 80/80/40/80;   Biological: Placebo (mcg) (Aluminum Adjuvant)225;   Biological: Placebo (mcg) (Aluminum Adjuvant) 450
2 Unknown  LANDA Embryo Freezing Technique.
Conditions: Primary Infertility;   Secondary Infertility;   Genital Diseases, Male;   Genital Diseases, Female
Intervention:
3 Active, not recruiting Activity, Tolerability, Safety of Temsirolimus in Women With Ovarian Cancer Who Progressed During Previous Platinum Chemotherapy or Within 6 Months After Therapy or Advanced Endometrial Carcinoma
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Endometrial Neoplasms
Intervention: Drug: Temsirolimus
4 Completed Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract
Conditions: Women's Health;   HIV Infection;   Genital Diseases, Female
Intervention:
5 Completed Prospective Evaluation of Lymphoedema Among Patients With Gynaecological Cancer
Conditions: Female Genital Diseases;   Ovarian Cancer;   Cervical Cancer;   Endometrial Cancer;   Vulval Cancer
Intervention:
6 Not yet recruiting Safety and Efficacy of Antiadhesive Barrier GUARDIX-FL for Women After Laparoscopic Cystectomy
Condition: Genital Diseases, Female
Interventions: Device: Guardix-FL;   Device: Interceed
7 Completed Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients
Conditions: Genital Diseases, Female;   Ovarian Neoplasms;   Urogenital Neoplasms
Intervention:
8 Completed A Study of Trabectedin in Patients With Advanced Ovarian Cancer
Conditions: Ovarian Neoplasms;   Endocrine Gland Neoplasms;   Neoplasms by Site;   Neoplasms;   Ovarian Diseases;   Adnexal Diseases;   Genital Diseases, Female
Interventions: Drug: Trabectedin;   Drug: Dexamethasone
9 Active, not recruiting Evaluation of Optimal Initial Treatment Duration of Bevacizumab in Combination With Standard Chemotherapy in Patients With Ovarian Cancer
Conditions: Genital Diseases, Female;   Ovarian Diseases;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms
Interventions: Biological: Bevacizumab;   Drug: Paclitaxel;   Drug: Carboplatin;   Other: specialized pathology review (Germany only)
10 Recruiting Effect of Salpingectomy During Conservative Hysterectomy
Conditions: Genital Diseases, Female;   Hysterotomy; Affecting Fetus;   Leiomyomata Uteri;   Adenomyosis, Endometriosis;   Dysfunctional Uterine Bleeding;   Cervical Dysplasia;   Uterine Prolapse
Interventions: Procedure: conservative hysterectomy I;   Procedure: Conservative hysterectomy II
11 Recruiting Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy
Conditions: Hysterectomy;   Genital Diseases, Female;   Pain
Interventions: Behavioral: Follow-up strategy;   Behavioral: No contact after discharge
12 Active, not recruiting Novel Topical Therapies for the Treatment of Genital Pain
Condition: Female Genital Diseases
Interventions: Drug: Amitriptyline;   Drug: Baclofen;   Drug: Ketoprofen;   Drug: Ketamine;   Drug: Loperamide;   Drug: Gabapentin;   Drug: placebo
13 Active, not recruiting GARDASIL™ Vaccine Impact in Population Study (V501-033)
Condition: Human Papillomavirus Infections
Intervention:
14 Active, not recruiting Prevention of HPV in 20 to 45 Year Old Chinese Women (V501-041)
Condition: HPV Infections
Interventions: Biological: Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine;   Biological: Comparator: placebo (unspecified)
15 Completed Eeva™ Continued Access Study: Assessing the Usability of Eeva in a Clinical Setting
Condition: Infertility
Intervention:
16 Not yet recruiting ADXS11-001 High Dose HPV+ Cervical Cancer
Conditions: Effects of Immunotherapy;   Metastatic/Recurrent Cervical Cancer;   Cervical Adenocarcinoma;   Cervical Adenosquamous Cell Carcinoma;   Cervical Squamous Cell Carcinoma;   Cervical Small Cell Carcinoma;   Stage III Cervical Cancer;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Intervention: Biological: ADXS11-001
17 Enrolling by invitation Prevention of Female Genital Schistosomiasis (FGS) in Rural High-endemic South Africa
Condition: Uro-genital Schistosomiasis
Intervention: Other: praziquantel
18 Active, not recruiting Weekly Paclitaxel/Carboplatin With Neupogen in Gynaecological Cancers
Conditions: Ovarian Cancer;   Endometrial Cancer;   Uterine Cervical Cancer
Interventions: Drug: Filgrastim;   Drug: Paclitaxel;   Drug: Carboplatin
19 Active, not recruiting A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
Conditions: Solid Tumors and Advanced Endometrial Cancer;   Endometrial Cancer;   Second-line Treatment;   VEGF
Intervention: Drug: TKI258
20 Unknown  Effect of Environmental Exposures on the Egg Fertilizing Ability of Human Sperm
Conditions: Male Infertility;   Testicular Diseases;   Urologic and Male Genital Diseases;   Lead Poisoning
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years